Event Date/Time: Oct 11, 2011
End Date/Time: Oct 13, 2011
Molecular diagnostic tools are driving innovation and investment, shaping a core business area in biotech, pharma and device companies. The shift toward developing diagnostic platforms comes from the advances in sequencing, microarrays, and microfluidics. The availability of new sequencing platforms and point-of-care assays will stimulate the growth in the field by providing greater speed, convenience and sensitivity, leading to improved outcomes and greater cost savings.